804561-30-6

Basic information

• Product Name: (2S,8R,11S)-2-(3-chlorophenyl)-8-methyl-11-(1-methylethyl)-1,5-dioxaspiro[5.5]undecane
• Synonyms: (2S,8R,11S)-2-(3-chlorophenyl)-8-methyl-11-(1-methylethyl)-1,5-dioxaspiro[5.5]undecane
• CAS NO: 804561-30-6
• Molecular Weight: 322.875
• Mol File: 804561-30-6.mol

Chemical Properties

• CAS DataBase Reference: (2S,8R,11S)-2-(3-chlorophenyl)-8-methyl-11-(1-methylethyl)-1,5-dioxaspiro[5.5]undecane(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,8R,11S)-2-(3-chlorophenyl)-8-methyl-11-(1-methylethyl)-1,5-dioxaspiro[5.5]undecane(804561-30-6)
• EPA Substance Registry System: (2S,8R,11S)-2-(3-chlorophenyl)-8-methyl-11-(1-methylethyl)-1,5-dioxaspiro[5.5]undecane(804561-30-6)

Safety Data

• Hazardous Substances Data: 804561-30-6(Hazardous Substances Data)

Upstream product

• 51699-45-7 (S)-(-)-1-(3'-Chlorophenyl)-1,3-Propanediol 
• 51699-40-2 3-(3-chlorophenyl)-3-hydroxypropionic acid ethyl ester 
• 587-04-2 m-Chlorobenzaldehyde 
• 99-02-5 3'-Chloroacetophenone 
• 33167-21-4 3-(3-chloro-phenyl)-3-oxo-propionic acid ethyl ester 

Downstream Products

• 625095-57-0 (S)-(-)-1-(3-Chlorophenyl)-1,3-propanediol 
• 1233960-52-5 cis-3-O-[4-(S)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]-18β-glycyrrhetinic acid 

Relevant articles and documents

Design, Synthesis, and Sustained-Release Property of 1,3-Cyclic Propanyl Phosphate Ester of 18β-Glycyrrhetinic Acid

A new class of potential prodrugs, 1,3-cyclic propanyl phosphate esters of 18β-glycyrrhetic acid, was designed and synthesized through the key reaction of 18β-glycyrrhetic acid with 1,3-cyclic propanyl phosphate ester catalysed by lithium diisopropylamide

Design, Synthesis, and Characterization of a Series of Cytochrome P 450 3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver

A new class of phosphate and phosphonate prodrugs, called HepDirect prodrugs, is described that combines properties of rapid liver cleavage with high plasma and tissue stability to achieve increased drug levels in the liver. The prodrugs are substituted c